Family Medicine · Rancho Cucamonga, CA
NPI
1306904628
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
10787 Laurel St
Rancho Cucamonga, CA, 91730
Phone (909) 982-7741
Groups this clinician bills Medicare through
Medicare paid, 2024
$403K
9,477 services
Medicare patients, 2024
665
Average age 75
Drug cost, 2024
$1.5M
17,839 prescriptions
Company payments, 2025
$1,745
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John A Fagan was code J0897 (injection, denosumab, 1 mg), 3,360 times for 31 patients. In total John A Fagan billed 9,477 services in 75 codes, and Medicare paid $403K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,360 | 31 | $18.90 | $63K |
| 99214 Office E&M - Established | Office | 915 | 418 | $86.64 | $79K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 833 | 86 | $48.26 | $40K |
| 99213 Office E&M - Established | Office | 755 | 419 | $61.59 | $47K |
| 99454 E&M - Miscellaneous | Office | 244 | 46 | $37.39 | $9,122 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 209 | 209 | $132.70 | $28K |
| 96372 Injection Administration | Office | 185 | 83 | $10.93 | $2,022 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 137 | 25 | $0.52 | $71.36 |
| 81002 Clinical Chemistry | Office | 116 | 65 | $3.41 | $396 |
| 99212 Office E&M - Established | Office | 112 | 64 | $40.57 | $4,544 |
| G0008 Administration of influenza virus vaccine | Office | 74 | 73 | $33.36 | $2,469 |
| 90662 Vaccine Product | Office | 73 | 72 | $80.74 | $5,894 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 64 | 13 | $0.71 | $45.74 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 62 | 35 | $38.08 | $2,361 |
| 93000 Electrocardiogram | Office | 56 | 51 | $10.51 | $589 |
By year: 2022 $349K for 7,285 services; 2023 $401K for 9,103 services; 2024 $403K for 9,477 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 116 | 65 | $3.41 | $396 |
Medicare prescription drug claims, 2024
In 2024, the drug John A Fagan prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,218 prescriptions and refills. In total John A Fagan wrote 17,839 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,218 | 3,168 | 340 | $12K |
| Levothyroxine Sodium Generic | 767 | 1,955 | 205 | $10K |
| Amlodipine Besylate Generic | 748 | 1,815 | 213 | $4,086 |
| Losartan Potassium Generic | 645 | 1,654 | 183 | $6,672 |
| Metformin Hcl Generic | 499 | 1,335 | 146 | $3,777 |
| Omeprazole Generic | 416 | 1,103 | 115 | $6,684 |
| Pantoprazole Sodium Generic | 392 | 780 | 90 | $6,282 |
| Lisinopril Generic | 377 | 1,015 | 109 | $2,534 |
| Gabapentin Generic | 332 | 558 | 86 | $5,352 |
| Hydrochlorothiazide Generic | 314 | 832 | 100 | $1,629 |
| Famotidine Generic | 274 | 580 | 77 | $3,614 |
| Metoprolol Succinate Generic | 271 | 654 | 74 | $4,078 |
| Duloxetine Hcl Generic | 257 | 467 | 66 | $5,147 |
| Simvastatin Generic | 247 | 655 | 78 | $1,774 |
| Tamsulosin Hcl Generic | 242 | 501 | 63 | $2,821 |
Brand drugs: 2,139 claims; generic drugs: 15,594 claims; opioid claims: 326.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John A Fagan $1,745 ($1,745 in general payments such as food, travel and fees) from 34 companies. The largest payer was Sumitomo Pharma America, Inc. with $181.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 8 | $181 |
| Abbvie Inc. ABBV | 11 | $150 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $150 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $99.04 |
| Exact Sciences Corporation EXAS | 5 | $98.44 |
| Corcept Therapeutics CORT | 4 | $94.69 |
| Lilly USA, LLC LLY | 4 | $83.59 |
| Novo Nordisk Inc NVO | 3 | $71.66 |
| Amgen Inc. AMGN | 4 | $71.1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $69.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.